Research Reports published by GEOJIT BNP PARIBAS

InterGlobe Aviation Ltd.    
09 Jun 2021
1776.40
-0.85%
buy
Geojit BNP Paribas
27% QoQ, led by recovery in passenger growth. Profitability was impacted by higher fuel cost, depreciation, lease rentals, & lower other income. Q1FY22 profitability is likely to be impacted by Covid second wave given sharp drop in passenger growth in April & May. However, we expect passenger traffic to pick-up gradually starting from Q2FY22 & expect revenue growth to normalize in H2FY22 led by acceleration in vaccination and as impact of Covid second wave subsides. Faster replacement of old aircrafts with 15% more fuel efficient fleets will improve profitability in the medium term....
default
Number of FII/FPI investors increased from 463 to 496 in Mar 2021 qtr.
Brokerage Research Reports    
TREND | 09 Jun 2021
Geojit BNP Paribas
Q4FY21 Net interest income shrunk 22.6% YoY, with domestic NIM contracting 102bps YoY to 2.16% Pre-provision operating profit fell 21.0% YoY while PAT reached Rs. 250cr, owing to lower provisioning in the quarter. We expect the credit costs and NIM margins to worsen on account of weak asset quality (particularly from stressed MSME segment). If Stimulus from government is announced, then it may act as turnaround catalyst for growth in loan book. However given current uncertainties,...
ICICI Securities Limited released a report for Brokerage Research Reports on 11 Jun, 2021.
NCC Ltd.    
08 Jun 2021
91.75
1.44%
buy
Buy: NCC Ltd.
Geojit BNP Paribas
NCC Limited (NCC) is one of the largest well diversified construction companies in India with a foothold in every segment of construction sector. Q4FY21 revenue grew by 20% YoY led by ramp up in execution on account of better availability of workforce. EBITDA margin declined by 179bps YoY to 11.1% due to higher input costs and higher sub-contracting expenses (54% YoY). Order book remain healthy at Rs37,911cr (5.2x FY21 revenue) supported by strong inflow of Rs18,953 in FY21. As per company, the second wave of Covid is expected to impact...
NCC Ltd. has gained 11.48% in the last 1 Week
Narayana Hrudayalaya Ltd.    
08 Jun 2021
485.20
-1.11%
Geojit BNP Paribas
Narayana Hrudayalaya Ltd (NH) is a chain of multi-specialty hospitals operating in India and the Cayman Islands. NH revenues in Q4FY21 grew by 12.8% YoY to Rs.838cr with strong...
Geojit BNP Paribas downgraded Narayana Hrudayalaya Ltd. to Accumulate with a price target of 561.0 on 08 Jun, 2021.
ITC Ltd.    
08 Jun 2021
207.30
-0.29%
buy
Buy: ITC Ltd.
Geojit BNP Paribas
ITC's business segments have been performing well on the back of demand growth, aiding topline performance. With margins expected to improve moving forward, we maintain our BUY rating on the stock with a revised target price of Rs. 256 based on SOTP valuation Decent performance in FMCG; Agri business outperforms Q4FY21 standalone revenue rose 24.1% YoY (+16% on comparable basis) to Rs. 14,023cr on account of robust recovery across all the segments boosted by increased demand for discretionary products. During the quarter, Cigarettes sales volumes...
ITC Ltd. has an average target of 242.44 from 10 brokers.
Brokerage Research Reports    
TREND | 08 Jun 2021
Geojit BNP Paribas
Indian bank is a mid-sized bank in the public sector, with a loan book size of Rs. 3.9 lakh crore and deposit base of Rs. 5.4 lakh crore. Allahabad Bank was merged with Indian Bank on 1st April 2020 and...
ICICI Securities Limited released a report for Brokerage Research Reports on 11 Jun, 2021.
TTK Prestige Ltd.    
07 Jun 2021
8855.70
-0.45%
buy
Accumulate: TTK Prestige Ltd.
Geojit BNP Paribas
Second wave of Covid-19 is likely to impact in the near-term, but longterm-demand outlook is positive given ongoing vaccination and strong thrust of GoI to revive the economy. We value TTK at 42xFY23E. Significant distribution expansion will support future growth. Q4FY21 consolidated revenue increased 43%YoY aided by revival across all categories & channels along with price hike (5%-19%). The core segments, Pressure Cooker and Cookware grew by 49% and 67%YoY respectively while Kitchen appliances grew by 34%YoY. E-Com sales growth continued to be strong and the revenue mix increased to 19% from 14% in FY20 (16% in Q3FY21). MFI (Micro Finance) routed sales were very...
TTK Prestige Ltd. is trading above all available SMAs
Bharat Forge Ltd.    
07 Jun 2021
740.70
-0.96%
Geojit BNP Paribas
Bharat Forge Ltd (BFL) is a leading player in the forgings industry. The company is serving several sectors including automobile, power, oil and gas, rail & marine, aerospace & defence, construction, mining, etc. Q4FY21 has witnessed a standalone revenue growth of 26.2%QoQ on the back of 43% growth in exports (US truck sales and Oil & Gas) and 9.6% growth in domestic revenues. Despite cost inflationary pressure, margin expanded by 680bps from Q3FY21, owing to superior product mix and cost control initiatives....
Number of FII/FPI investors increased from 448 to 455 in Mar 2021 qtr.
Brokerage Research Reports    
TREND | 05 Jun 2021
Geojit BNP Paribas
Amara Raja Batteries Ltd (ARBL) is India's second largest Lead-acid battery manufacturer. Its segment includes 70% from automotive & rest from industrial with market leadership in the Telecom segment. During Q4FY21, ARBL revenue came at 33%YoY led by lower base and demand recovery both in OEM and replacement sales. Margin came lower at 15.1% (-30bps) due to higher lead price. However, continued cost control initiatives offset the further decline. Investment of Rs350cr for technological & capacity up-gradation in the...
ICICI Securities Limited released a report for Brokerage Research Reports on 11 Jun, 2021.
Strides Pharma Science Ltd.    
03 Jun 2021
817.80
-1.18%
Geojit BNP Paribas
The emerging markets grew by 107% YoY with growth in institutional biz. driven by TDL. The company announced its partnership with TLC to launch Amphotericin B Liposome for Injection 50mg. We expect a revenue CAGR of 15% over FY21E-FY23E on the back of strong existing product portfolio, new product basket to aid COVID treatment and strengthening of front-end presence. Hence, we upgrade our rating from Accumulate to Buy based on...
Strides Pharma Science Ltd. is trading above it's 200 day SMA of 790.5